Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Biofrontera AG - Filing #6464128

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Das sonstige Ergebnis nach Steuern enthält lediglich Umrechnungsdifferenzen aus der Umrechnung des Geschäftsbetriebs in Fremdwährung in die Konzernwährung.
Description of functional currency
Der Konzernabschluss zum 31. Dezember 2024 wird in EUR (bzw. TEUR), der funktionalen Währung der deutschen in den Konzernabschluss einbezogenen Unternehmen, und der Darstellungswährung des Konzerns, aufgestellt.
Description of presentation currency
EUR
Reserve of exchange differences on translation
22,000 EUR
1,000 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
13,399 EUR
13,012 EUR
Current assets
16,255 EUR
17,720 EUR
Non-current liabilities
329,000 EUR
678,000 EUR
Current liabilities
10,469 EUR
10,073 EUR
Revenue
21,666 EUR
32,249 EUR
Profit (loss)
4,350 EUR
0 EUR
0 EUR
0 EUR
4,350 EUR
369,000 EUR
0 EUR
369,000 EUR
0 EUR
Other comprehensive income
21,000 EUR
0 EUR
0 EUR
21,000 EUR
0 EUR
0 EUR
1,000 EUR
0 EUR
0 EUR
1,000 EUR
Comprehensive income
4,329 EUR
0 EUR
0 EUR
21,000 EUR
4,350 EUR
0 EUR
368,000 EUR
0 EUR
369,000 EUR
1,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.